TOMASSI, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 1.728
NA - Nord America 1.294
EU - Europa 966
SA - Sud America 233
AF - Africa 53
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.277
Nazione #
US - Stati Uniti d'America 1.248
SG - Singapore 763
RU - Federazione Russa 512
CN - Cina 340
VN - Vietnam 273
IT - Italia 213
BR - Brasile 186
HK - Hong Kong 162
FR - Francia 44
DE - Germania 41
BD - Bangladesh 37
IN - India 36
CI - Costa d'Avorio 28
GB - Regno Unito 28
NL - Olanda 25
CA - Canada 24
JP - Giappone 24
KR - Corea 23
FI - Finlandia 17
MX - Messico 13
PH - Filippine 13
AR - Argentina 12
AT - Austria 12
BG - Bulgaria 12
EC - Ecuador 11
IE - Irlanda 11
CO - Colombia 9
IQ - Iraq 9
PL - Polonia 9
SE - Svezia 9
UA - Ucraina 9
ID - Indonesia 8
TH - Thailandia 8
PK - Pakistan 6
TW - Taiwan 6
BE - Belgio 5
CL - Cile 5
HR - Croazia 5
MA - Marocco 5
ES - Italia 4
NP - Nepal 4
PY - Paraguay 4
TR - Turchia 4
ZA - Sudafrica 4
EG - Egitto 3
AU - Australia 2
ET - Etiopia 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
NI - Nicaragua 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
NE - Niger 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 4.277
Città #
Singapore 377
San Jose 193
Hong Kong 157
Chandler 143
Moscow 116
Ashburn 101
Beijing 99
Ho Chi Minh City 83
Hefei 71
Santa Clara 68
Los Angeles 49
Hanoi 47
The Dalles 38
Lauterbourg 34
Naples 33
Millbury 31
Dallas 25
Boston 23
Des Moines 23
Lawrence 22
Napoli 22
Dong Ket 20
Tokyo 20
Amsterdam 18
Buffalo 18
Council Bluffs 17
São Paulo 16
Redondo Beach 15
Seoul 15
Milan 14
New York 14
Munich 12
Sofia 12
Wilmington 12
Nanjing 11
Tianjin 11
Kochi 9
Princeton 9
Warsaw 9
Frankfurt am Main 8
Ottawa 8
Chicago 7
Da Nang 7
Haiphong 7
Mexico City 7
Nuremberg 7
Porto Alegre 7
Stockholm 7
Brooklyn 6
Ha Long 6
Memphis 6
Ninh Bình 6
Seattle 6
Amorosi 5
Belo Horizonte 5
Biên Hòa 5
Can Tho 5
Denver 5
Florence 5
Lappeenranta 5
London 5
Rio de Janeiro 5
Turku 5
Vienna 5
Zagreb 5
Baghdad 4
Brussels 4
Caserta 4
Charlotte 4
Chennai 4
Dhaka 4
Guayaquil 4
Hải Dương 4
Phoenix 4
Piombino 4
Quito 4
Ribeirão Preto 4
Rome 4
Shanghai 4
Toronto 4
Ankara 3
Atlanta 3
Bologna 3
Davao City 3
Düsseldorf 3
Florianópolis 3
Hebei 3
Manchester 3
Montreal 3
Mumbai 3
Nanchang 3
Norwalk 3
Orem 3
Querétaro 3
Redwood City 3
San Francisco 3
Santiago 3
Serra 3
Suzhou 3
São José 3
Totale 2.282
Nome #
Click-Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga-68-Peptide: Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts 182
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 159
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 154
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 141
A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors 135
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 134
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 131
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 124
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 124
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells 123
Combined HAT/EZH2 modulation leads to cancer-selective cell death 122
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides 119
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 116
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 115
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach 114
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand 111
A novel smaller β‐defensin‐derived peptide is active against multidrug‐resistant bacterial strains 109
Investigation of the stereochemical-dependent DNA and RNA binding of arginine-based nucleopeptides 106
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 105
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells 103
From PARP1 to TNKS2 Inhibition: A Structure-Based Approach 98
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34 97
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 97
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment 97
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3‐d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 96
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities 95
Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones 94
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor. 93
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins 92
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8 88
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 77
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactions 75
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers 73
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands 70
Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity 70
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 68
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides 63
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 63
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists 63
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells 62
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 59
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 59
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 56
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders 55
Totale 4.387
Categoria #
all - tutte 13.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 2 0 2 1 6 19 5 9 12 13 24 76
2022/2023301 37 22 21 11 42 45 2 36 48 20 11 6
2023/2024188 8 30 12 9 5 14 12 39 9 3 34 13
2024/20251.177 56 105 5 15 13 93 136 71 65 124 398 96
2025/20262.267 228 242 245 217 367 48 270 124 229 132 88 77
2026/202710 10 0 0 0 0 0 0 0 0 0 0 0
Totale 4.387